Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 11 studies | 32% ± 15% | |
fibroblast | 10 studies | 23% ± 10% | |
endothelial cell | 10 studies | 31% ± 9% | |
plasma cell | 7 studies | 27% ± 9% | |
ciliated cell | 7 studies | 28% ± 9% | |
goblet cell | 6 studies | 33% ± 17% | |
platelet | 6 studies | 27% ± 7% | |
macrophage | 6 studies | 22% ± 6% | |
respiratory goblet cell | 5 studies | 27% ± 14% | |
microglial cell | 5 studies | 27% ± 7% | |
myofibroblast cell | 5 studies | 23% ± 6% | |
secretory cell | 4 studies | 22% ± 6% | |
pancreatic A cell | 4 studies | 54% ± 21% | |
classical monocyte | 4 studies | 26% ± 8% | |
non-classical monocyte | 4 studies | 27% ± 8% | |
hematopoietic precursor cell | 4 studies | 23% ± 11% | |
kidney loop of Henle epithelial cell | 4 studies | 22% ± 3% | |
pericyte | 4 studies | 20% ± 4% | |
endothelial cell of artery | 4 studies | 17% ± 2% | |
abnormal cell | 4 studies | 31% ± 13% | |
basal cell | 4 studies | 30% ± 8% | |
club cell | 4 studies | 25% ± 8% | |
squamous epithelial cell | 3 studies | 34% ± 19% | |
type B pancreatic cell | 3 studies | 61% ± 16% | |
conventional dendritic cell | 3 studies | 33% ± 9% | |
connective tissue cell | 3 studies | 38% ± 9% | |
smooth muscle cell | 3 studies | 17% ± 2% | |
mucus secreting cell | 3 studies | 24% ± 1% | |
dendritic cell | 3 studies | 33% ± 13% | |
pancreatic ductal cell | 3 studies | 54% ± 22% | |
megakaryocyte | 3 studies | 34% ± 8% | |
enteroendocrine cell | 3 studies | 24% ± 8% | |
transit amplifying cell | 3 studies | 21% ± 4% | |
hepatocyte | 3 studies | 44% ± 21% | |
plasmacytoid dendritic cell | 3 studies | 26% ± 8% | |
neuron | 3 studies | 29% ± 18% | |
renal alpha-intercalated cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 5248.71 | 966 / 966 | 100% | 183.94 | 527 / 527 |
lung | 100% | 7239.90 | 578 / 578 | 100% | 219.71 | 1155 / 1155 |
pancreas | 100% | 13780.91 | 328 / 328 | 100% | 234.54 | 178 / 178 |
prostate | 100% | 8661.79 | 245 / 245 | 100% | 241.14 | 502 / 502 |
stomach | 100% | 8345.22 | 359 / 359 | 100% | 178.53 | 286 / 286 |
esophagus | 100% | 3793.49 | 1444 / 1445 | 100% | 177.92 | 183 / 183 |
ovary | 100% | 7624.24 | 180 / 180 | 100% | 142.64 | 429 / 430 |
thymus | 100% | 9317.25 | 653 / 653 | 100% | 245.26 | 603 / 605 |
breast | 100% | 6192.59 | 459 / 459 | 100% | 211.12 | 1113 / 1118 |
uterus | 100% | 6441.33 | 170 / 170 | 99% | 153.28 | 455 / 459 |
kidney | 100% | 9420.79 | 89 / 89 | 99% | 148.78 | 893 / 901 |
liver | 100% | 9046.73 | 226 / 226 | 99% | 168.92 | 402 / 406 |
skin | 100% | 6346.56 | 1808 / 1809 | 99% | 160.48 | 467 / 472 |
bladder | 100% | 6950.00 | 21 / 21 | 99% | 220.07 | 498 / 504 |
adrenal gland | 100% | 10661.89 | 258 / 258 | 97% | 129.85 | 223 / 230 |
brain | 86% | 2383.72 | 2269 / 2642 | 100% | 103.38 | 703 / 705 |
adipose | 100% | 5643.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 10205.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 110.51 | 29 / 29 |
spleen | 100% | 4923.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 110.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 284.67 | 1 / 1 |
peripheral blood | 99% | 4951.84 | 923 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 111.66 | 78 / 80 |
heart | 91% | 3337.57 | 783 / 861 | 0% | 0 | 0 / 0 |
muscle | 8% | 123.04 | 63 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0006915 | Biological process | apoptotic process |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0006914 | Biological process | autophagy |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0006417 | Biological process | regulation of translation |
GO_0070513 | Molecular function | death domain binding |
Gene name | DAP |
Protein name | Death-associated protein Death-associated protein 1 (DAP-1) Death associated protein (cDNA FLJ55133, weakly similar to Death-associated protein 1) |
Synonyms | hCG_37855 DAP1 |
Description | FUNCTION: Ribosome-binding protein involved in ribosome hibernation, a process during which ribosomes are stabilized in an inactive state and preserved from proteasomal degradation (By similarity). Acts via its association with eiF5a (EIF5A and EIF5A2) at the polypeptide exit tunnel of the ribosome, preventing mRNA translation (By similarity). Involved in ribosome hibernation in the mature oocyte by preventing mRNA translation, leading to ribosome inactivation (By similarity). Ribosomes, which are produced in large quantities during oogenesis, are stored and translationally repressed in the oocyte and early embryo (By similarity). Also acts as a negative regulator of autophagy . Involved in mediating interferon-gamma-induced cell death . . |
Accessions | B4DQ75 ENST00000230895.11 P51397 ENST00000432074.2 Q7KZT7 |